CAPTRUST FINANCIAL ADVISORS - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 11 filers reported holding MONOPAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
1700.0%0.00%
Q4 2021$1,0000.0%1700.0%0.00%
Q3 2021$1,0000.0%1700.0%0.00%
Q2 2021$1,0000.0%1700.0%0.00%
Q1 2021$1,0000.0%1700.0%0.00%
Q4 2020$1,0000.0%1700.0%0.00%
Q2 2020$1,0001700.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
American Portfolios Advisors 700$4,1230.00%
ROYAL BANK OF CANADA 5,130$30,0000.00%
VANGUARD GROUP INC 97,462$574,0000.00%
Paragon Wealth Strategies, LLC 58$00.00%
WELLS FARGO & COMPANY/MN 27$00.00%
NORTHERN TRUST CORP 36,106$213,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 28,761$169,0000.00%
MORGAN STANLEY 4,000$24,0000.00%
BlackRock Inc. 15,046$89,0000.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders